9/14/2006 9:18:37 AM ET


    SWISS MEDICA ANNOUNCES SOUTH AFRICA DISTRIBUTION DEAL FOR O24™
      
    FOR IMMEDIATE RELEASE

    Stock Symbol: OTC BB: SWME
    September 14, 2006

    Toronto, Canada – Swiss Medica, Inc. (OTC BB: SWME) announced today that Heritage Healthcare of the
    Republic of South Africa has become Swiss Medica’s latest international distribution partner. Heritage Healthcare
    will be marketing and distributing Swiss Medica’s O24 products throughout South Africa (“SA”).

    Heritage Healthcare will be commencing a national marketing campaign which will include promoting O24 into the
    major pharmacy chains and distributors and sampling the O24™ products to orthopedic surgeons,
    physiotherapists and pain management specialists in South Africa.

    According to Gary Schach, Founder of Heritage Healthcare:

    “South Africans are sports crazy and many suffer from pain caused by over-doing activities whilst participating in
    soccer, rugby, athletics, tennis, running and golf. I personally have 26 years experience in developing,
    manufacturing and marketing healthcare and surgical products to the SA market and feel certain that O24™ will
    soon become a leading contender in the natural product pain relief sector in South Africa.”

    Grant Johnson, President and COO of Swiss Medica stated “We are proud to see the international healthcare
    community recognize and support the strengths of our brands: all-natural, clinically-tested products that provide
    fast, safe and effective relief. It is our goal to continue to grow Swiss Medica’s international presence through
    these strategic distribution deals. We expect to make several more announcements regarding our international
    expansion plans over the next several months.”

    About the Heritage Health
    Heritage Healthcare is a division of Heritage Surgical Products cc of South Africa who is an innovative leader in
    the manufacture and supplier of unique, high quality urological, incontinence, surgical and medical products
    servicing the South African marketplace. Heritage Healthcare has a strong and respected relationship with many
    healthcare professionals, pharmacists and allied professionals throughout South Africa. The Republic of South
    Africa has a population of 42.4 million, a Gross Domestic Product in 2005 of $570 Billion (18th highest
    Worldwide) and a per capital income of $12,160 (54th highest in the world).


    About Swiss Medica, Inc.

    Swiss Medica is a specialty pharmaceutical company focused on commercializing over-the-counter clinically-
    tested, patented all-natural products that relieve chronic ailments. Swiss Medica builds its brands through
    innovative and focused distribution and marketing strategies. Swiss Medica's mission is to be a world leader in
    the commercialization of over-the-counter, safe and effective chronic ailment treatments. Please visit our
    websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.

    Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain
    relief solution has been used and recommended for its fast-acting and long-lasting benefits by healthcare
    professionals and athletes in the United States, Canada and in Europe. O24™ is widely available over-the-
    counter throughout the United States and Canada in leading pharmacies and other retailers. Customers can
    also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.

    Swiss Medica has recently launching the patented O24 Fibromyalgia™ pain reliever (US Patent #6,444,238B1)
    over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded
    O24 Fibromyalgia™ their first NFA Seal of Approval. Over 10 million Americans suffer from the long-term pain
    associated with fibromyalgia. In a randomized double blind clinical trial conducted in 2005, 88 per cent of the
    patients who used O24 Fibromyalgia™ reported mild to markedly better improvement, versus only 7 per cent
    who used the placebo. Customers can also visit www.O24zone.com for ordering details and store locators for the
    nearest retailer.

    Swiss Medica also distributes PMS Escape® which holds US Patent #'s 5760014 and 5612320. PMS Escape® is
    a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in
    mood and appetite that women experience during the premenstrual period. Customers can also visit:
    www.pmsescape.com for additional information and ordering details.

    Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
    United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
    statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
    transactions being contemplated, risks related to international sales and potential foreign currency exchange
    fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological
    changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's
    periodic reports filed with the United States Securities and Exchange Commission and other regulatory
    authorities.

    For more information, please contact:

1